Abstracts (HTML) List of Authors

Habermann, J

Development of idiotype-specific vNAR-CAR-immune cells for the treatment of clonal malignancies

Haeupl, B

Breaking the pump: targeting the sodium-potassium pump as a therapeutic strategy in acute myeloid leukemia

Hagenbourger, F

Characterization of cooperating mechanisms in GATA2 syndrome

Hähnel, K

Clonal Hematopoiesis in Patients with Severe Congenital Neutropenia

Hartmann, M

Back to the roots – multi-omics as a road atlas to the cell-of-origin in rare childhood leukemia

Häselbarth, L

Targeting metabolism effectively complements tyrosine kinase inhibitor treatment of chronic myeloid leukemia

Häupl, B

The proteogenomic subtypes of acute myeloid leukemia

Heckl, D

Upstream regulation of DLK1-DIO3 locus in hematopoiesis and pediatric leukemia
A CRISPR-based platform to model AML progression using primary human cells
Identifying gene targets for drug repurposing to preventing myeloid malignancies
Deciphering the molecular mechanism of NUP98-KDM5A chromosomal translocation in pediatric non-DS-AMKL
CRISPRi proliferation and differentiation screening to identify functional long noncoding RNAs in pediatric AML

Hehir-Kwa, J

Epigenetic modifiers direct lineage switch in MLL-AF4 leukemia

Heidenreich, O

Efficient Expansion of Immature Acute Myeloid Leukaemia Cells in an Ex Vivo Co-culture System
Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation
Targeting the unique barcode of MLL/AF4
RUNX1/ETO effects on the interactions with t(8;21) AML with bone marrow niche: lessons from scRNAseq
Deep learning-based cell segmentation identifies T cell infiltration and spatial distribution in de novo pediatric AML
Understanding the FLT3-ITD maintenance and relapse pathways by RNAi screens
Ex vivo and in vivo complex drug combination analysis for improved efficacy and specificity in high-risk childhood acute lymphoblastic leukaemia
Characterizing alternative splicing landscape by RUNX1/ETO reveals novel vulnerabilities in t(8;21) leukemia
Epigenetic modifiers direct lineage switch in MLL-AF4 leukemia

Heim, C

ErbB2-CAR mediated immunotherapy for the treatment of high-risk rhabdomyosarcoma

Henssen, AG

Application of mediator probe PCR chemistry in multiplex target assays for monitoring MRD of high-risk neuroblastoma

Herbst, J

CRISPR/Cas9-based generation of CAR-expressing natural killer-like cells against acute myeloid leukemia

Hernandez, B

De novo design of cytokines, antikines, and novokines

Herold, T

Streamlining preclinical in vivo treatment trials by multiplexing genetically labelled PDX models in a single mouse
ADAM10’s sheddase function augments the interaction of leukemia cells with the bone marrow niche in PDX models in vivo

Hettich-Woggon, I

Clonal Hematopoiesis in Patients with Severe Congenital Neutropenia

Heyn, H

A single-cell expression atlas of human AML-LScs unravels the contribution of HIF pathway and its therapeutic potential

Hinze, L

SOD2 Promotes Acute Leukemia Adaptation to Amino Acid Starvation Through the N-Degron Pathway

Hoefler, L

Selinexor, a selective inhibitor of XPO-1, shows antitumor activity in rhabdomyosarcoma cell lines

Höfener, H

Comprehensive bone marrow analysis integrating deep learning-based pattern discovery (BMDeep)

Hudecek, M

High antileukemic efficiency of CD19-CAR NK cells engineered with Sleeping Beauty transposon vectors

Hunt, K

Streamlining preclinical in vivo treatment trials by multiplexing genetically labelled PDX models in a single mouse

Hust, M

CRISPR/Cas9-based generation of CAR-expressing natural killer-like cells against acute myeloid leukemia